regulatory
confidence high
sentiment negative
materiality 0.90
BIOLASE, INC: Nasdaq/NYSE listing notice — BIOLASE receives Nasdaq delisting notice; stock bid price below $0.10 for 10 days
BIOLASE, INC
- Nasdaq notified BIOLASE on June 8, 2023 that its common stock had a closing bid price of $0.10 or less for 10 consecutive trading days (May 24 – June 7, 2023).
- Trading suspension and delisting from Nasdaq Capital Market set for June 20, 2023, unless a hearing is requested.
- Company plans to timely request a hearing before the Nasdaq Hearings Panel to stay the suspension pending a decision.
- Previous deficiency notice on January 11, 2023 for bid price below $1.00; 180-day grace period expires July 10, 2023.